These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32376976)

  • 21. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Factors for Eye Globe Salvage by External Beam Radiation Therapy for Resistant Intraocular Retinoblastoma.
    Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Mehyar M; Al-Nawaiseh I
    Oman J Ophthalmol; 2020; 13(3):123-128. PubMed ID: 33542599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review.
    Weng PY; Chen SH; Kao LY; Tsai YJ; Yang SH; Tseng CK; Tsay PK; Jaing TH
    Medicine (Baltimore); 2020 Sep; 99(38):e22201. PubMed ID: 32957352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of primarily treated group D retinoblastoma.
    Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
    Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
    Ophthalmology; 2022 Aug; 129(8):933-945. PubMed ID: 35500608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.
    Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL
    Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China.
    Gao J; Zeng J; Guo B; He W; Chen J; Lu F; Chen D
    Medicine (Baltimore); 2016 Oct; 95(42):e5204. PubMed ID: 27759657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
    Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
    Rao R; Honavar SG; Reddy VP
    Br J Ophthalmol; 2019 Dec; 103(12):1856-1861. PubMed ID: 30796055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.
    Fabian ID; Naeem Z; Stacey AW; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
    Am J Ophthalmol; 2017 Jul; 179():137-144. PubMed ID: 28501391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.
    Tomar AS; Finger PT; Gallie B; Kivelä T; Mallipatna A; Zhang C; Zhao J; Wilson M; Brennan R; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganeshan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef Y; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada GL; Schaiquevich P; Fandiño AC; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa Llano M; Carreras E; ;
    Br J Ophthalmol; 2023 Jan; 107(1):127-132. PubMed ID: 34340974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.